Overview
Atrial fibrillation ablation.
Cardiac resynchronization therapy.
Implantable defibrillator, including inappropriate shocks.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Hypertrophic cardiomyopathy.
Long QT syndrome
Sudden cardiac arrest and resuscitation.
Ventricular tachycardia
Cardiac resynchronization therapy.
Implantable defibrillator, including inappropriate shocks.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Hypertrophic cardiomyopathy.
Long QT syndrome
Sudden cardiac arrest and resuscitation.
Ventricular tachycardia
Current Duke Appointments & Affiliations
Professor of Medicine
·
2010 - Present
Medicine, Cardiology,
Medicine
Recent Scholarly Works
2026 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (Revision of the 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology): A Report of the ACC Competency Management Committee.
Journal article Circ Arrhythm Electrophysiol · May 2026 Full text Link to item Cite2026 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (Revision of the 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology): A Report of the ACC Competency Management Committee.
Journal article J Am Coll Cardiol · April 22, 2026 Full text Link to item CiteSex-Based Differences in Left Bundle Branch Capture During Left Bundle Branch Area Pacing.
Journal article Pacing Clin Electrophysiol · February 25, 2026 OBJECTIVE: To identify sex-based differences in meeting left bundle branch (LBB) capture criteria on postimplant ECGs. BACKGROUND: Despite differences in QRS duration (QRSd) between males and females, no sex-based criteria have been established for definin ... Full text Link to item CiteRecent Grants
PKP2 Dose Escalation Trial of RP-A601
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2024 - 2029The Natural History of Arrhythmogenic Cardiomyopathy with Pathogenic PKP2 Variants (PKP2-ACM): An observational cohort study
Clinical TrialPrincipal Investigator · Awarded by Rocket Pharmaceuticals, Ltd · 2025 - 2029A Phase 2 Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia
Clinical TrialPrincipal Investigator · Awarded by Cardurion Pharmaceuticals, Inc. · 2025 - 2027View All Grants
Education
Thomas Jefferson University ·
1984
M.D.